Science News
Targeting specific gut bacteria and their metabolites could offer new ways to prevent or treat cardiovascular disease linked to diet and gut health.
Gianfranco Grompone, scientific director at BioGaia, explored innovative strategies for developing next-generation probiotics, with a focus on Limosilactobacillus reuteri SM1738.
Emmanuel Perrin, Advanced Technology Ingredients Senior Director Danone, explores Danone’s vision for harnessing the microbiome to guide the next generation of nutrition solutions.
Maintaining healthy T cells is key to preserving gut health and preventing chronic inflammation that drives aging-related diseases.
By revealing that OTUD3 limits microbiota-driven STING activation, the findings of a new study offer insights into the disease mechanisms of ulcerative colitis and may pave the way to new…
Jan Knol, Senior Director Research & Innovation at Danone Nutricia Research, discusses about the present and the future of microbiome research.
For Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, the message is clear: how we feed and protect our microbiome determines the clinical outcome.
Engineered bacteria can be used in gut therapies, but maintaining control over their colonization and genetic stability remains challenging.
Probiotics protect against obesity and inflammation caused by high sugar intake, supporting their use as a preventive strategy for obesity-related diabetes.
Mahesh Desai, group leader of the Eco-Immunology and Microbiome team at the Luxembourg Institute of Health and adjunct associate professor at the University of Southern Denmark, discusses about his research…
Maternal oral microbiota plays a key role in influencing infant gut health and disease risk.
A recent study highlights formate as a potential target to boost cancer treatment.
Recent studies have identified various bacterial and fungal pathobionts in patients with CD and UC.
Patrick Veiga, Gut Microbiome & Nutrition Research Director at INRAE (France), discusses one of the major challenges in probiotic research: the variability of clinical trial outcomes.
Professor Alessandro Gramenzi discusses the current knowledge of the gut microbiota in companion animals and the opportunities to modulate it through nutritional interventions.
Calcium ions affect the growth of both L. acidophilus ATCC 4356 and L. plantarum ATCC 14917, despite some differences.
Breastfeeding and Bifidobacterium are key factors in shaping the infant resistome and could offer strategies to reduce antibiotic resistance early in life.
Prebiotic EN positively influenced certain gut bacteria, including Lactobacillus rhamnosus and Faecalicatena gnavus, and antibiotic resistance gene expression.
Managing gut health might be important for fertility treatments.
Specific gut bacteria are important in early life for healthy immune development.
